ArticleEuropean radiology2020

Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.

Kye Jin Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.